NTRK fusion gene EQA

Posted 21/04/2020

Today NICE has recommended VITRAKVIĀ® (larotrectinib) for the treatment of advanced neurotrophic tyrosine receptor kinase (NTRK) fusion-positive solid tumours in adult and paediatric patients in England.  Ensure your NTRK test quality with our EQA!

Go to top